NEW YORK, Dec 21 - Aurora Biosciences said Thursday that Bristol-Myers Squibb’s Pharmaceutical Research Institute has validated Aurora’s ultra-high throughput screening system, the UHTSS Platform.

This is the first time one of Aurora’s development partners has validated a complete UHTSS Platform, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.